Fig. 5. Overall survival comparing TPEx regimen and EXTREME regimen - "Highlights for the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting"
Merry Jennifer Markham on LinkedIn: #asco23
ASCOcancer
Proportion of female presenters and abstract authors over time at
Full article: Highlights from ASCO 2019
Highlights - JADPRO
ASCO GU 2023: Ending Cancer as We Know It: Predicting Future
Figure 5 from Highlights for the 2019 American Society of Clinical
Figure 5 from Highlights for the 2019 American Society of Clinical
ASCO Annual Meeting 2019 Highlights